|
SFRS5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.976600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.334800E-01 |
| Normal-vs-Stage2 |
9.201400E-01 |
| Normal-vs-Stage3 |
3.622000E-01 |
| Normal-vs-Stage4 |
1.068970E-01 |
| Stage1-vs-Stage2 |
3.085000E-01 |
| Stage1-vs-Stage3 |
1.827890E-02 |
| Stage1-vs-Stage4 |
3.758000E-03 |
| Stage2-vs-Stage3 |
4.947400E-01 |
| Stage2-vs-Stage4 |
2.016000E-01 |
| Stage3-vs-Stage4 |
4.305000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.497400E-01 |
| Normal-vs-AfricanAmerican |
2.177600E-02 |
| Normal-vs-Asian |
3.115200E-01 |
| Caucasian-vs-AfricanAmerican |
5.753400E-04 |
| Caucasian-vs-Asian |
2.925800E-01 |
| AfricanAmerican-vs-Asian |
7.715000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.954000E-01 |
| Normal-vs-Female |
5.462000E-02 |
| Male-vs-Female |
6.06730000000111E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.492400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.421400E-01 |
| Normal-vs-Age(61-80Yrs) |
7.446800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.651200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.035200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.636200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.600200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.992000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.051200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.738200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.56209999999857E-05 |
| Normal-vs-Grade 2 |
8.740000E-02 |
| Normal-vs-Grade 3 |
2.380000E-01 |
| Normal-vs-Grade 4 |
1.856840E-03 |
| Grade 1-vs-Grade 2 |
4.058800E-03 |
| Grade 1-vs-Grade 3 |
1.3157999999569E-06 |
| Grade 1-vs-Grade 4 |
3.9336000012824E-08 |
| Grade 2-vs-Grade 3 |
2.563600E-04 |
| Grade 2-vs-Grade 4 |
1.31439999995209E-06 |
| Grade 3-vs-Grade 4 |
1.244440E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.470400E-02 |
| Normal-vs-ccB subtype |
6.962200E-03 |
| ccA subtype-vs-ccB subtype |
1.29319999153665E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.197000E-01 |
| Normal-vs-N1 |
4.238300E-04 |
| N0-vs-N1 |
2.3170999999933E-05 |
|
|
